He Yu-Qin, Zhang Xi-Wei, Zhu Yi-Ming, Ni Xiao-Guang, Huang Ze-Hao, An Chang-Ming, Yi Jun-Lin, Liu Shao-Yan
Department of Head and Neck Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China.
Department of Endoscopy, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China.
Front Oncol. 2021 Jan 8;10:600599. doi: 10.3389/fonc.2020.600599. eCollection 2020.
We aimed to analyze the relationship between the changed status of vocal cord mobility and survival outcomes.
Seventy-eight patients with dysfunctional vocal cords and hypopharyngeal carcinomas accepted non-surgical treatment as the initial therapy between May 2009 and December 2016. Vocal cord mobility was assessed before and after the initial non-surgical treatment. The cord mobility status was classified as normal, impaired, and fixed. Patients with improved mobility (IM) (n =56) were retrospectively analyzed for disease-free survival (DFS), recurrence-free survival (RFS), and overall survival (OS) and compared with 22 patients with non-improved mobility (non-IM).
Fifty-six (71.8%) patients had improved cord mobility after the initial non-surgical treatment. The non-improved cord mobility was significantly associated with shortened DFS (0.005), RFS (0.002), and OS (<0.001). If non-improved cord mobility was regarded as an indicator for local-regional recurrence within 1 year, the sensitivity and the specificity were 60.9%, 87.5% respectively. The multivariate analysis showed that improved cord mobility (0.006) and salvage surgery (0.015) were both independent protective factors for OS.
Changes in cord mobility are a key marker for predicting prognosis. Non-improved cord mobility may indicate a high possibility of a residual tumor, therefore, patients whose cord mobility remains dysfunctional or worsens after non-surgical treatment might need an aggressive salvage strategy.
我们旨在分析声带活动度变化状态与生存结果之间的关系。
2009年5月至2016年12月期间,78例声带功能障碍合并下咽癌患者接受了非手术治疗作为初始治疗。在初始非手术治疗前后评估声带活动度。声带活动度状态分为正常、受损和固定。对活动度改善(IM)的患者(n = 56)进行无病生存期(DFS)、无复发生存期(RFS)和总生存期(OS)的回顾性分析,并与22例活动度未改善(非IM)的患者进行比较。
56例(71.8%)患者在初始非手术治疗后声带活动度得到改善。声带活动度未改善与DFS缩短(0.005)、RFS缩短(0.002)和OS缩短(<0.001)显著相关。如果将声带活动度未改善视为1年内局部区域复发的指标,其敏感性和特异性分别为60.9%、87.5%。多因素分析显示,声带活动度改善(0.006)和挽救性手术(0.015)均为OS的独立保护因素。
声带活动度变化是预测预后的关键指标。声带活动度未改善可能表明残留肿瘤的可能性较高,因此,非手术治疗后声带活动度仍功能障碍或恶化的患者可能需要积极的挽救策略。